LVIP JPMorgan Small Cap Core Fund HALO Holdings History
Number of Shares
17,717.00
Current Holdings Value*
$1.13 Mil
% of Portfolio
0.64%
Total Estimate Gain
$-26,752.67
% of Total Estimate Gain
-2.60%
LVIP JPMorgan Small Cap Core Fund's Halozyme Therapeutics Inc Holding Summary
As of 2025-03-31, LVIP JPMorgan Small Cap Core Fund held 17,717.00 shares of Halozyme Therapeutics Inc(HALO), totaling $1.13 Mil. This investment constitutes 0.64% of their stock portfolio, and LVIP JPMorgan Small Cap Core Fund now holds 0.01% of the outstanding Halozyme Therapeutics Inc(HALO) stock.
The initial trade took place in 2025Q1. And since then LVIP JPMorgan Small Cap Core Fund has made 1 purchases of HALO, at an average price of $58.09, for a total of 17,717.00 shares. Based on historical transaction data and HALO's current price of $56.58, LVIP JPMorgan Small Cap Core Fund's estimated gain on his HALO holdings is $-26,752.67, reflecting a -2.60% gain to date.
LVIP JPMorgan Small Cap Core Fund HALO ($56.58) Holding Chart
LVIP JPMorgan Small Cap Core Fund HALO ($56.58) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1